MİRİLİ, C. Et Al. 2019. LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION. Namık Kemal Medical Journal (NKMJ) , vol.7, no.3 , 271-278.

MİRİLİ, C., PAYDAŞ, S., BÜYÜKŞİMŞEK, M., TOHUMCUOĞLU, M., yetişir, a. e., & OĞUL, A., (2019). LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION. Namık Kemal Medical Journal (NKMJ) , vol.7, no.3, 271-278.

MİRİLİ, CEM Et Al. "LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION," Namık Kemal Medical Journal (NKMJ) , vol.7, no.3, 271-278, 2019

MİRİLİ, CEM Et Al. "LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION." Namık Kemal Medical Journal (NKMJ) , vol.7, no.3, pp.271-278, 2019

MİRİLİ, C. Et Al. (2019) . "LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION." Namık Kemal Medical Journal (NKMJ) , vol.7, no.3, pp.271-278.

@article{article, author={CEM MİRİLİ Et Al. }, title={LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION}, journal={Namık Kemal Medical Journal (NKMJ)}, year=2019, pages={271-278} }